{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T01:39:05Z","timestamp":1794274745604,"version":"4.9.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"8089","license":[{"start":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T00:00:00Z","timestamp":1757462400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T00:00:00Z","timestamp":1757462400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nature"],"published-print":{"date-parts":[[2025,11,13]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Monogenic lupus offers valuable insights into the underlying mechanisms and therapeutic approaches for systemic lupus erythematosus (SLE)\n                    <jats:sup>1\u20133<\/jats:sup>\n                    . Here we report on five patients with SLE carrying recessive mutations in phospholipase D family member 4 (\n                    <jats:italic>PLD4<\/jats:italic>\n                    ). Deleterious variants in\n                    <jats:italic>PLD4<\/jats:italic>\n                    resulted in impaired single-stranded nucleic acid exonuclease activity in in vitro and ex vivo assays.\n                    <jats:italic>PLD4<\/jats:italic>\n                    loss-of-function mutations led to excessive activation of Toll-like receptor 7 (TLR7) and TLR9. Downstream inflammatory signalling pathways, especially type I interferon signalling, were hyperactivated in patient dendritic cells.\n                    <jats:italic>Pld4<\/jats:italic>\n                    -deficient mice presented with autoimmunity and cell-intrinsic expansion of plasmacytoid dendritic cells and plasma cells.\n                    <jats:italic>Pld4<\/jats:italic>\n                    -deficient mice responded to the JAK inhibitor baricitinib, suggesting that targeting type I interferon may be a potential therapy for patients with PLD4 deficiency.\n                  <\/jats:p>","DOI":"10.1038\/s41586-025-09513-x","type":"journal-article","created":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T15:04:08Z","timestamp":1757516648000},"page":"498-505","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Loss-of-function mutations in PLD4 lead to systemic lupus erythematosus"],"prefix":"10.1038","volume":"647","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6884-3408","authenticated-orcid":false,"given":"Qintao","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Honghao","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangwei","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9041-0788","authenticated-orcid":false,"given":"Changming","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuangyue","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinjian","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenlu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahui","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruoran","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0290-1286","authenticated-orcid":false,"given":"Qing","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6981-5772","authenticated-orcid":false,"given":"Xiaomin","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6093-0726","authenticated-orcid":false,"given":"Zhihong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,10]]},"reference":[{"key":"9513_CR1","doi-asserted-by":"crossref","first-page":"712","DOI":"10.3390\/jcm9030712","volume":"9","author":"E Demirkaya","year":"2020","unstructured":"Demirkaya, E., Sahin, S., Romano, M., Zhou, Q. & Aksentijevich, I. New horizons in the genetic etiology of systemic lupus erythematosus and lupus-like disease: monogenic lupus and beyond. J. Clin. Med. 9, 712 (2020).","journal-title":"J. Clin. Med."},{"key":"9513_CR2","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/s41586-022-04642-z","volume":"605","author":"GJ Brown","year":"2022","unstructured":"Brown, G. J. et al. TLR7 gain-of-function genetic variation causes human lupus. Nature 605, 349\u2013356 (2022).","journal-title":"Nature"},{"key":"9513_CR3","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.3389\/fimmu.2018.02496","volume":"9","author":"JM Alperin","year":"2018","unstructured":"Alperin, J. M., Ortiz-Fernandez, L. & Sawalha, A. H. Monogenic lupus: a developing paradigm of disease. Front. Immunol. 9, 2496 (2018).","journal-title":"Front. Immunol."},{"key":"9513_CR4","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/nrneph.2015.33","volume":"11","author":"C Mohan","year":"2015","unstructured":"Mohan, C. & Putterman, C. Genetics and pathogenesis of systemic lupus erythematosus and lupus nephritis. Nat. Rev. Nephrol. 11, 329\u2013341 (2015).","journal-title":"Nat. Rev. Nephrol."},{"key":"9513_CR5","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.autrev.2010.08.014","volume":"10","author":"A Doria","year":"2010","unstructured":"Doria, A. et al. SLE diagnosis and treatment: when early is early. Autoimmun. Rev. 10, 55\u201360 (2010).","journal-title":"Autoimmun. Rev."},{"key":"9513_CR6","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/nri.2016.78","volume":"16","author":"M Schlee","year":"2016","unstructured":"Schlee, M. & Hartmann, G. Discriminating self from non-self in nucleic acid sensing. Nat. Rev. Immunol. 16, 566\u2013580 (2016).","journal-title":"Nat. Rev. Immunol."},{"key":"9513_CR7","doi-asserted-by":"crossref","first-page":"e1526250","DOI":"10.1080\/2162402X.2018.1526250","volume":"7","author":"M Smith","year":"2018","unstructured":"Smith, M. et al. Trial watch: toll-like receptor agonists in cancer immunotherapy. Oncoimmunology 7, e1526250 (2018).","journal-title":"Oncoimmunology"},{"key":"9513_CR8","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.immuni.2007.09.009","volume":"27","author":"JA Deane","year":"2007","unstructured":"Deane, J. A. et al. Control of toll-like receptor 7 expression is essential to restrict autoimmunity and dendritic cell proliferation. Immunity 27, 801\u2013810 (2007).","journal-title":"Immunity"},{"key":"9513_CR9","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.immuni.2011.10.009","volume":"35","author":"ML Mouchess","year":"2011","unstructured":"Mouchess, M. L. et al. Transmembrane mutations in Toll-like receptor 9 bypass the requirement for ectodomain proteolysis and induce fatal inflammation. Immunity 35, 721\u2013732 (2011).","journal-title":"Immunity"},{"key":"9513_CR10","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.cell.2020.02.041","volume":"180","author":"KA Fitzgerald","year":"2020","unstructured":"Fitzgerald, K. A. & Kagan, J. C. Toll-like receptors and the control of immunity. Cell 180, 1044\u20131066 (2020).","journal-title":"Cell"},{"key":"9513_CR11","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.cell.2010.01.022","volume":"140","author":"O Takeuchi","year":"2010","unstructured":"Takeuchi, O. & Akira, S. Pattern recognition receptors and inflammation. Cell 140, 805\u2013820 (2010).","journal-title":"Cell"},{"key":"9513_CR12","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.immuni.2020.06.014","volume":"53","author":"E Bartok","year":"2020","unstructured":"Bartok, E. & Hartmann, G. Immune sensing mechanisms that discriminate self from altered self and foreign nucleic acids. Immunity 53, 54\u201377 (2020).","journal-title":"Immunity"},{"key":"9513_CR13","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1038\/ni1141","volume":"5","author":"M Colonna","year":"2004","unstructured":"Colonna, M., Trinchieri, G. & Liu, Y. J. Plasmacytoid dendritic cells in immunity. Nat. Immunol. 5, 1219\u20131226 (2004).","journal-title":"Nat. Immunol."},{"key":"9513_CR14","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1136\/ard-2022-223741","volume":"82","author":"MK Crow","year":"2023","unstructured":"Crow, M. K. Pathogenesis of systemic lupus erythematosus: risks, mechanisms and therapeutic targets. Ann. Rheum. Dis. 82, 999\u20131014 (2023).","journal-title":"Ann. Rheum. Dis."},{"key":"9513_CR15","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/nature11502","volume":"491","author":"JJ Ipsaro","year":"2012","unstructured":"Ipsaro, J. J., Haase, A. D., Knott, S. R., Joshua-Tor, L. & Hannon, G. J. The structural biochemistry of Zucchini implicates it as a nuclease in piRNA biogenesis. Nature 491, 279\u2013283 (2012).","journal-title":"Nature"},{"key":"9513_CR16","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S1388-1981(99)00094-3","volume":"1439","author":"M Waite","year":"1999","unstructured":"Waite, M. The PLD superfamily: insights into catalysis. Biochim. Biophys. Acta 1439, 187\u2013197 (1999).","journal-title":"Biochim. Biophys. Acta"},{"key":"9513_CR17","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1152\/physrev.1997.77.2.303","volume":"77","author":"JH Exton","year":"1997","unstructured":"Exton, J. H. Phospholipase D: enzymology, mechanisms of regulation, and function. Physiol. Rev. 77, 303\u2013320 (1997).","journal-title":"Physiol. Rev."},{"key":"9513_CR18","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1038\/s41590-018-0179-y","volume":"19","author":"AL Gavin","year":"2018","unstructured":"Gavin, A. L. et al. PLD3 and PLD4 are single-stranded acid exonucleases that regulate endosomal nucleic-acid sensing. Nat. Immunol. 19, 942\u2013953 (2018).","journal-title":"Nat. Immunol."},{"key":"9513_CR19","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-021-26150-w","volume":"12","author":"AL Gavin","year":"2021","unstructured":"Gavin, A. L. et al. Cleavage of DNA and RNA by PLD3 and PLD4 limits autoinflammatory triggering by multiple sensors. Nat. Commun. 12, 5874 (2021).","journal-title":"Nat. Commun."},{"key":"9513_CR20","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1038\/s41577-021-00577-0","volume":"22","author":"NA Lind","year":"2022","unstructured":"Lind, N. A., Rael, V. E., Pestal, K., Liu, B. & Barton, G. M. Regulation of the nucleic acid-sensing Toll-like receptors. Nat. Rev. Immunol. 22, 224\u2013235 (2022).","journal-title":"Nat. Rev. Immunol."},{"key":"9513_CR21","doi-asserted-by":"crossref","first-page":"6820","DOI":"10.1016\/j.cell.2024.09.036","volume":"187","author":"S Singh","year":"2024","unstructured":"Singh, S. et al. PLD3 and PLD4 synthesize S,S-BMP, a key phospholipid enabling lipid degradation in lysosomes. Cell 187, 6820\u20136834 (2024).","journal-title":"Cell"},{"key":"9513_CR22","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.str.2024.02.019","volume":"32","author":"M Yuan","year":"2024","unstructured":"Yuan, M. et al. Structural and mechanistic insights into disease-associated endolysosomal exonucleases PLD3 and PLD4. Structure 32, 766\u2013779 (2024).","journal-title":"Structure"},{"key":"9513_CR23","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1016\/j.immuni.2024.04.010","volume":"57","author":"M B\u00e9routi","year":"2024","unstructured":"B\u00e9routi, M. et al. Lysosomal endonuclease RNase T2 and PLD exonucleases cooperatively generate RNA ligands for TLR7 activation. Immunity 57, 1482\u20131496 (2024).","journal-title":"Immunity"},{"key":"9513_CR24","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1136\/annrheumdis-2018-214116","volume":"78","author":"S Akizuki","year":"2019","unstructured":"Akizuki, S. et al. PLD4 is a genetic determinant to systemic lupus erythematosus and involved in murine autoimmune phenotypes. Ann. Rheum. Dis. 78, 509\u2013518 (2019).","journal-title":"Ann. Rheum. Dis."},{"key":"9513_CR25","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-023-38501-w","volume":"14","author":"ZP Van Acker","year":"2023","unstructured":"Van Acker, Z. P. et al. Phospholipase D3 degrades mitochondrial DNA to regulate nucleotide signaling and APP metabolism. Nat. Commun. 14, 2847 (2023).","journal-title":"Nat. Commun."},{"key":"9513_CR26","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1038\/s41577-021-00524-z","volume":"21","author":"A Decout","year":"2021","unstructured":"Decout, A., Katz, J. D., Venkatraman, S. & Ablasser, A. The cGAS\u2013STING pathway as a therapeutic target in inflammatory diseases. Nat. Rev. Immunol. 21, 548\u2013569 (2021).","journal-title":"Nat. Rev. Immunol."},{"key":"9513_CR27","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1136\/jcp.56.7.481","volume":"56","author":"CC Mok","year":"2003","unstructured":"Mok, C. C. & Lau, C. S. Pathogenesis of systemic lupus erythematosus. J. Clin. Pathol. 56, 481\u2013490 (2003).","journal-title":"J. Clin. Pathol."},{"key":"9513_CR28","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1681\/ASN.2022040477","volume":"34","author":"J Peng","year":"2023","unstructured":"Peng, J. et al. Clinical implications of a new DDX58 pathogenic variant that causes lupus nephritis due to RIG-I hyperactivation. J. Am. Soc. Nephrol. 34, 258\u2013272 (2023).","journal-title":"J. Am. Soc. Nephrol."},{"key":"9513_CR29","volume":"9","author":"C Wolf","year":"2024","unstructured":"Wolf, C. et al. UNC93B1 variants underlie TLR7-dependent autoimmunity. Sci. Immunol. 9, eadi9769 (2024).","journal-title":"Sci. Immunol."},{"key":"9513_CR30","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.immuni.2018.08.015","volume":"49","author":"SA Jenks","year":"2018","unstructured":"Jenks, S. A. et al. Distinct effector B cells induced by unregulated toll-like receptor 7 contribute to pathogenic responses in systemic lupus erythematosus. Immunity 49, 725\u2013739 (2018).","journal-title":"Immunity"},{"key":"9513_CR31","doi-asserted-by":"crossref","first-page":"4525","DOI":"10.4049\/jimmunol.1400098","volume":"192","author":"SW Jackson","year":"2014","unstructured":"Jackson, S. W. et al. Opposing impact of B cell-intrinsic TLR7 and TLR9 signals on autoantibody repertoire and systemic inflammation. J. Immunol. 192, 4525\u20134532 (2014).","journal-title":"J. Immunol."},{"key":"9513_CR32","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1002\/eji.200838138","volume":"38","author":"AM Fairhurst","year":"2008","unstructured":"Fairhurst, A. M. et al. Yaa autoimmune phenotypes are conferred by overexpression of TLR7. Eur. J. Immunol. 38, 1971\u20131978 (2008).","journal-title":"Eur. J. Immunol."},{"key":"9513_CR33","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.immuni.2006.07.013","volume":"25","author":"SR Christensen","year":"2006","unstructured":"Christensen, S. R. et al. Toll-like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus. Immunity 25, 417\u2013428 (2006).","journal-title":"Immunity"},{"key":"9513_CR34","volume":"15","author":"H Ni","year":"2024","unstructured":"Ni, H. et al. Cyclical palmitoylation regulates TLR9 signalling and systemic autoimmunity in mice. Nat. Commun. 15, 1 (2024).","journal-title":"Nat. Commun."},{"key":"9513_CR35","doi-asserted-by":"crossref","first-page":"3172","DOI":"10.1172\/JCI132328","volume":"130","author":"JS Tilstra","year":"2020","unstructured":"Tilstra, J. S. et al. B cell-intrinsic TLR9 expression is protective in murine lupus. J. Clin. Invest. 130, 3172\u20133187 (2020).","journal-title":"J. Clin. Invest."},{"key":"9513_CR36","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1038\/s41590-022-01310-2","volume":"23","author":"C Leibler","year":"2022","unstructured":"Leibler, C. et al. Genetic dissection of TLR9 reveals complex regulatory and cryptic proinflammatory roles in mouse lupus. Nat. Immunol. 23, 1457\u20131469 (2022).","journal-title":"Nat. Immunol."},{"key":"9513_CR37","doi-asserted-by":"crossref","first-page":"577","DOI":"10.4049\/immunohorizons.2300058","volume":"7","author":"AL Gavin","year":"2023","unstructured":"Gavin, A. L. et al. Disease in the Pld4thss\/thss model of murine lupus requires TLR9. Immunohorizons 7, 577\u2013586 (2023).","journal-title":"Immunohorizons"},{"key":"9513_CR38","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.coi.2016.10.006","volume":"44","author":"SK Panda","year":"2017","unstructured":"Panda, S. K., Kolbeck, R. & Sanjuan, M. A. Plasmacytoid dendritic cells in autoimmunity. Curr. Opin. Immunol. 44, 20\u201325 (2017).","journal-title":"Curr. Opin. Immunol."},{"key":"9513_CR39","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1186\/s13075-023-03186-5","volume":"25","author":"K Yasaka","year":"2023","unstructured":"Yasaka, K. et al. Phospholipase D4 as a signature of toll-like receptor 7 or 9 signaling is expressed on blastic T-bet+ B cells in systemic lupus erythematosus. Arthritis Res. Ther. 25, 200 (2023).","journal-title":"Arthritis Res. Ther."},{"key":"9513_CR40","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1038\/ni.3777","volume":"18","author":"K Manthiram","year":"2017","unstructured":"Manthiram, K., Zhou, Q., Aksentijevich, I. & Kastner, D. L. The monogenic autoinflammatory diseases define new pathways in human innate immunity and inflammation. Nat. Immunol. 18, 832\u2013842 (2017).","journal-title":"Nat. Immunol."},{"key":"9513_CR41","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1002\/art.37777","volume":"65","author":"C Terao","year":"2013","unstructured":"Terao, C. et al. PLD4 as a novel susceptibility gene for systemic sclerosis in a Japanese population. Arthritis Rheum. 65, 472\u2013480 (2013).","journal-title":"Arthritis Rheum."},{"key":"9513_CR42","doi-asserted-by":"crossref","first-page":"64180","DOI":"10.18632\/oncotarget.19419","volume":"8","author":"WC Chen","year":"2017","unstructured":"Chen, W. C. et al. rs2841277 (PLD4) is associated with susceptibility and rs4672495 is associated with disease activity in rheumatoid arthritis. Oncotarget 8, 64180\u201364190 (2017).","journal-title":"Oncotarget"},{"key":"9513_CR43","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/nrrheum.2013.157","volume":"10","author":"W Xiong","year":"2014","unstructured":"Xiong, W. & Lahita, R. G. Pragmatic approaches to therapy for systemic lupus erythematosus. Nat. Rev. Rheumatol. 10, 97\u2013107 (2014).","journal-title":"Nat. Rev. Rheumatol."},{"key":"9513_CR44","doi-asserted-by":"crossref","unstructured":"Wang, Y. et al. Identification of an IL-1 receptor mutation driving autoinflammation directs IL-1-targeted drug design. Immunity 56, 1485\u20131501 (2023).","DOI":"10.1016\/j.immuni.2023.05.014"},{"key":"9513_CR45","doi-asserted-by":"crossref","unstructured":"Hao, Y. et al. Integrated analysis of multimodal single-cell data. Cell 184, 3573\u20133587 (2021).","DOI":"10.1016\/j.cell.2021.04.048"},{"key":"9513_CR46","unstructured":"DeLano, W. L. PyMOL: an open-source molecular graphics tool. CCP4 Newsl. Protein Crystallogr. 40, 82\u201392 (2002)."},{"key":"9513_CR47","doi-asserted-by":"crossref","unstructured":"Chen, T. et al. The genome sequence archive family: toward explosive data growth and diverse data types. Genom. Proteom. Bioinformatics 19, 578\u2013583 (2021).","DOI":"10.1016\/j.gpb.2021.08.001"},{"key":"9513_CR48","unstructured":"CNCB-NGDC Members and Partners. Database resources of the National Genomics Data Center, China National Center for Bioinformation in 2025. Nucleic Acids Res. 53, D30\u2013D44 (2025)."}],"updated-by":[{"DOI":"10.1038\/s41586-025-09692-7","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T00:00:00Z","timestamp":1760054400000}}],"container-title":["Nature"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41586-025-09513-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41586-025-09513-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41586-025-09513-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,16]],"date-time":"2025-11-16T23:03:34Z","timestamp":1763334214000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41586-025-09513-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,10]]},"references-count":48,"journal-issue":{"issue":"8089","published-print":{"date-parts":[[2025,11,13]]}},"alternative-id":["9513"],"URL":"https:\/\/doi.org\/10.1038\/s41586-025-09513-x","relation":{},"ISSN":["0028-0836","1476-4687"],"issn-type":[{"value":"0028-0836","type":"print"},{"value":"1476-4687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,10]]},"assertion":[{"value":"17 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2025","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41586-025-09692-7","URL":"https:\/\/doi.org\/10.1038\/s41586-025-09692-7","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}